Ngā hua rapu - Pamela Lockbaum

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer

    Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer mā Eric K. Rowinsky, Garry Schwartz, Jared Gollob, John A. Thompson, Nicholas J. Vogelzang, Robert A. Figlin, Ronald M. Bukowski, Naomi B. Haas, Pamela Lockbaum, Yu-Ping Li, Rosalin Arends, Kenneth A. Foon, Gisela Schwab, Janice Dutcher

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans

    A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans mā Graham Molineux, Olaf Kinstler, Bob Briddell, Cynthia Hartley, Patricia McElroy, Patrick J. Kerzic, Weston Sutherland, Greg Stoney, Brent Kern, Frederick A. Fletcher, Art Cohen, Elliot Korach, Tom Ulich, Ian McNiece, Pamela Lockbaum, Mary Ann Miller‐Messana, Sheila Gardner, Thomas R. Hunt, G Schwab

    I whakaputaina 1999
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: